Can tretinoin (all-trans retinoic acid) thin the skin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Tretinoin Thin the Skin?

No, tretinoin does not thin the skin—it actually thickens the epidermis while improving dermal structure. This is a common misconception that contradicts the histological evidence showing tretinoin increases viable epidermal thickness and enhances dermal components.

Evidence of Skin Thickening, Not Thinning

Epidermal Changes

  • Tretinoin produces marked increases in viable epidermal thickness by approximately 28-30% after 48 weeks of treatment, compared to an 11% decrease with vehicle control 1
  • This epidermal thickening occurs in both photodamaged skin and intrinsically aged, non-sun-exposed skin 2
  • The treatment creates a more undulating dermoepidermal junction with prominent rete ridges, indicating enhanced epidermal architecture 2

Dermal Improvements

  • Tretinoin increases dermal vascularity by 89-100% compared to vehicle (which showed a 9% decrease), reflecting enhanced blood vessel formation 1
  • Dermal changes include increased glycosaminoglycan deposition and elastic fiber formation 2
  • These structural improvements occur through extensive changes in both epidermis and dermis during treatment 3

Why the Confusion Exists

Skin Fragility vs. Actual Thinning

The misconception likely stems from temporary skin sensitivity and fragility that occurs during tretinoin treatment, which is fundamentally different from actual skin thinning:

  • Common side effects include dry skin, peeling, scaling, flaking, burning sensation, and erythema 4, 5
  • This "retinoid dermatitis" can make skin feel more sensitive and fragile, particularly during the first 3-9 weeks 6, 7
  • For patients with severe erythroderma and pre-existing skin fragility (like Netherton syndrome), retinoids may increase fragility and should be used cautiously 6

Distinction from Systemic Retinoids

The evidence provided discusses systemic retinoids (acitretin, isotretinoin) causing mucocutaneous side effects including "thinning, redness and scaling of the skin" 6, but this refers to increased sensitivity and fragility, not histological thinning. Even with systemic retinoids, the concern is about increased skin sensitivity making walking and grasping objects difficult 6, not actual dermal or epidermal atrophy.

Clinical Implications

Patient Counseling

  • Reassure patients that the temporary sensitivity and peeling does not represent skin thinning but rather represents active cellular turnover and remodeling 4, 7
  • The skin may feel more fragile initially, but structural measurements show thickening, not thinning 2, 1
  • Initial worsening may occur between 3-9 weeks before improvement is seen 7

Sun Protection is Critical

  • Avoid excessive sun exposure and use effective sunscreen because tretinoin increases photosensitivity, not because the skin is thinner 4, 5
  • The increased sensitivity to UV light is due to active cellular remodeling, not reduced skin thickness 7

Managing Irritation

  • Start with lower concentrations (0.025% or 0.05%) to minimize irritation while achieving similar efficacy to higher concentrations 7, 1
  • Both 0.1% and 0.025% tretinoin produce similar clinical and histologic improvements, but 0.025% causes significantly less irritation 1
  • If irritation is excessive, reduce frequency to every other day until tolerance develops 7

References

Research

Effects of topical tretinoin on non-sun-exposed protected skin of the elderly.

Journal of the American Academy of Dermatology, 1993

Guideline

Tretinoin Cream Prescription Instructions for Acne and Fine Wrinkles

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tretinoin Treatment for Acne Vulgaris

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tretinoin for Keratosis Pilaris Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.